Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-19Clinical Trial Update: Effect of Celecoxib on Markers of Vascular Inflammation [Phase 4]
Phase 4 trial evaluating Celecoxib's effect on markers of vascular inflammation in patients with hypertension and coronary artery disease; t…
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes [NA]
This update reports the completion of a clinical trial evaluating whether case-management with home monitoring improves diabetes and hyperte…
-
CLINICAL_TRIALS trial_result · 2011-09-14Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension [Phase 2]
This update reports the completion of a Phase 2 trial evaluating PS433540 for hypertension and that the results have been posted.
-
FDA approval · 2011-09-13FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for Atenolol by Zydus Lifesciences Limited under an ANDA, authorizing an approved supplemental actio…
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension [Phase 2]
Phase 2 clinical trial update reporting dose-related efficacy and safety findings for PS433540 in hypertension; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)
Clinical trial evaluating whether losartan protects kidney function in hypertensive diabetic patients with microalbuminuria has completed; r…
-
CLINICAL_TRIALS research · 2011-09-07Clinical Trial Update: Real Life Experience of the Use of Isomers as ALENCAL (Levamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients
This clinical trial update reports real-life experience using levamlodipine, marketed as ALENCAL, in Colombian patients to evaluate efficacy…
-
CLINICAL_TRIALS research · 2011-09-05Clinical Trial Update: A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia [NA]
A large, multi-site, individually randomized trial is evaluating integrated care strategies to reduce cardiovascular disease risk among adul…
-
CLINICAL_TRIALS trial_result · 2011-09-01Clinical Trial Update: Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)
A completed clinical trial evaluating MK-0954A for managing hypertension by reducing uric acid; results posted in 2011.
-
FDA approval · 2011-08-31FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for amlodipine besylate from Aurobindo Pharma Limited, authorizing continued marketing of the ge…
-
FDA approval · 2011-08-31FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin's supplemental application for a generic fixed-dose combination of amlodipine besylate and benazepril hydrochloride f…
-
FDA approval · 2011-08-31FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for a generic fixed-dose combination of amlodipine besylate and benazepril hydrochloride (Dr. Re…
-
CLINICAL_TRIALS trial_result · 2011-08-31Clinical Trial Update: Real-life Experience of the Use of Isomers as METPURE XL (S (-) Metoprolol Succinate) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients
Real-life experience using METPURE XL (S(-) metoprolol succinate) to evaluate efficacy, safety and tolerability in Colombian patients with c…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy [Phase 4]
Phase 4 clinical trial assessing the effect of valsartan on left ventricular function in patients with hypertension and left ventricular hyp…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial [Phase 3]
The TROPHY Phase 3 trial evaluating candesartan cilexetil for long-term prevention of hypertension has completed.
-
FDA approval · 2011-08-29FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for bisoprolol fumarate by TruPharma LLC, under an ANDA.
-
FDA approval · 2011-08-29FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for the generic fixed-dose combination of bisoprolol fumarate and hydrochlorothiazide from Unichem P…
-
FDA approval · 2011-08-29FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's supplemental application for bisoprolol fumarate, confirming approval of a generic product. The approval per…
-
FDA approval · 2011-08-26FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) submitted by Organon LLC.
-
FDA approval · 2011-08-21FDA Approved: TENORETIC — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Tenoretic (atenolol and chlorthalidone) from Upsher-Smith Laboratories, LLC. The approval pertai…
-
FDA approval · 2011-08-19FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
FDA approved Oceanside Pharmaceuticals' supplemental application for diltiazem hydrochloride, allowing continued marketing of this generic p…
-
FDA approval · 2011-08-17FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for Tenormin (atenolol) from Almatica Pharma LLC.
-
FDA approval · 2011-08-17FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Hydrochlorothiazide from Alembic Pharmaceuticals Limited, adding a generic version of the diuret…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome [Phase 2]
Phase 2 trial comparing aliskiren and amlodipine in hypertensive patients with metabolic syndrome, evaluating effects on insulin resistance …
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: An Open-labeled Trial of Ramipril in Patients With Migraine [Phase 2]
Phase 2 open-label trial of ramipril in patients with migraine and hypertension has completed.